Conversations in Lung Cancer Research
by Thoracic Oncology Group Of Australasia (TOGA)
Welcome to Conversations in Lung Cancer Research, presented by TOGA, your go-to podcast for in-depth insights into lung cancer. Tune in for conversations with leading experts, inspiring stories, and the latest updates on clinical trials. Stay informed and empowered in the fight against lung cancer.
Episodes
-
The Evolving Role of Radiation Oncology in Lung Cancer Management
In this episode of TOGA's Conversations in Lung Cancer Research, host Prof. Shalini Vinod (Radiation Oncologist, Liverpool Hospital, Sydney) and guests Dr. Dasantha Jayamanne (Radiation Oncologist, Royal North Shore Hospital, Sydney, and GenesisCare) and Dr. Jane Ludbrook (Radiation Oncologist,...
-
Bispecific Antibodies in Thoracic Oncology
In this episode of TOGA's Conversations in Lung Cancer Research, host Dr. Samantha Bowyer (Sir Charles Gairdner Hospital, Perth), alongside A/Prof Rachel Roberts-Thomson (The Queen Elizabeth Hospital, Adelaide) and A/Prof Abhijit Pal (Liverpool and Bankstown Hospitals, Sydney), examine the…
more -
Targeting VEGF in Thoracic Oncology
In this episode of Conversations in Lung Cancer Research, host A/Prof Prunella Blinman (Medical Oncologist from Concord Hospital, Sydney) is joined by world-leading thoracic medical oncologists Prof Nick Pavlakis (Royal North Shore Hospital, Sydney) and Prof Sanjay Popat (The Royal Marsden...
-
The Evolving Landscape of ROS1-positive NSCLC
In this episode of TOGA's Conversations in Lung Cancer Research, host A/Prof Steven Kao, Medical Oncologist at Chris O'Brien Lifehouse, is joined by A/Prof Venessa Chin, Medical Oncologist at St Vincent's Hospital and Researcher at the Garvan Institute of Medical Research, and Dr Ben Kong…
more -
Prof Zarnie Lwin OAM: Mentorship, Research, and the Future of Lung Cancer Treatment
In this episode of TOGA's Conversations in Lung Cancer Research, host A/Prof Mel Moore welcomes Prof Zarnie Lwin OAM (University of Queensland; Medical Oncologist at Royal Brisbane and Women’s Hospital and The Prince Charles Hospital) to discuss her pathway from Burma to training in South Africa...
-
Smoking Stigma and Lung Cancer Care in the Screening Era
In this episode of TOGA's Conversations in Lung Cancer Research, host A/Prof Gavin Wright sits down with a multidisciplinary panel of experts to tackle the critical and complex issue of smoking-related stigma in lung cancer. The conversation explores how social constructs and industry...
-
Dr. Jazmin Eckhaus: Robotic Innovations and Ethics in Thoracic Surgery
In this episode of 'Conversations in Lung Cancer Research,' host A/Prof Mel Moore interviews Dr. Jazmin Eckhaus, a practising surgeon in the subspecialty of thoracic surgery, and specialising in minimally invasive thoracic surgery and pleural disease. Dr. Eckhaus discusses her extensive training...
-
Immunotherapy in Thoracic Cancers: Applying Broad IO Access Across Thoracic Malignancies
In this second part of TOGA's Conversations in Lung Cancer Research two-episode series, A/Prof Adnan Nagrial, a Medical Oncologist at Westmead Hospital, leads a panel discussing the clinical implications of the March 1st broad Pharmaceutical Benefits Scheme (PBS) listing of ipilimumab and…
more -
Immunotherapy in Thoracic Cancers: From Indication-Based to Biology-Driven
In this first part of a special two-episode series of TOGA's Conversations in Lung Cancer Research podcast, A/Prof Deme Karikios, a Medical Oncologist at the Nepean Hospital in NSW, is joined by Prof Ken O'Byrne, a Consultant and Professor in Medical Oncology at the Princess Alexandra Hospital…
more -
The Evolving Landscape of BRAF-Mutated NSCLC in Australia
In this episode of TOGA's Conversations in Lung Cancer Research, host A/Prof Rachel Roberts-Thomson, a Medical Oncologist at The Queen Elizabeth Hospital and Cancer Care Adelaide, leads a panel discussion focusing on the landscape of BRAF-mutated non-small cell lung cancer. Joined by Prof Ahn...
-
Thymic Cancer: The Lesser-Known Thoracic Tumours
In this episode of TOGA's Conversations in Lung Cancer Research, host A/Prof Malinda Itchins, a medical oncologist and clinician researcher at Royal North Shore Hospital and Chris O'Brien Lifehouse , leads a practical overview of managing thymic cancers in Australia and New Zealand. She is joined...
-
A/Prof Surein Arulananda: A Masterclass in Career Growth
In this episode of TOGA's 'Conversations in Lung Cancer Research,' A/Prof Mel Moore interviews A/Prof Surein Arulananda, the interim Director of Medical Oncology and Thoracic Oncology Trials Lead at Monash Health and Convenor at the 2026 TOGA ASM. They discuss his academic background, his...
-
TOGA ASM 2026: Program Review
In this episode of 'Conversations in Lung Cancer Research,' host A/Prof Surein Arulananda (Medical Oncologist, Monash Health) is joined by members of the Local Organising Committee to provide an exclusive preview of the 2026 TOGA Annual Scientific Meeting (ASM). The panel discusses the most...
-
ALK TKI Sequencing in the Australian Landscape
In this episode of TOGA's Conversations in Lung Cancer Research, host A/Prof Tim Clay sits down with Australian oncology luminaries Prof Ben Solomon and A/Prof Malinda Itchins to discuss the rapidly evolving landscape of Anaplastic Lymphoma Kinase (ALK) positive lung cancer. Since its discovery…
more -
Professor Michael Millward: Clinical Insights in Lung Cancer Research
In this episode of 'Conversations in Lung Cancer Research,' A/Prof Mel Moore talks with Prof Michael Millward, Foundation Professor of Clinical Cancer Research at the University of Western Australia and the oncology Medical Director at Linear Clinical Research in Perth. They discuss Prof…
more -
Dr. Megan Sanders: From Science to TOGA Leadership
In this episode of Conversations in Lung Cancer Research, host A/Prof Mel Moore interviews Dr. Megan Sanders, the Chief Executive Officer of TOGA. They discuss Megan's journey from working in vaccine formulation to earning a PhD in immunology, working in clinical trials, and eventually leading...
-
Lung Cancer Research: 2025 Year in Review
In this episode of 'Conversations in Lung Cancer Research,' hosted by Associate Professor Mal Itchens, a multidisciplinary panel delves into the ongoing advancements in lung cancer research in Australia and New Zealand. The panel includes Professor Nick Pavlakis from Royal North Shore Hospital…
more -
New and Emerging Practice Standards in ES-SCLC
In this episode of 'Conversations in Lung Cancer Research,' host Dr. Rebecca Tay and fellow oncologists A/Prof Surein Arulananda and Dr. Dasantha Jayamanne (DJ) delve into the latest advances in small cell lung cancer treatment. They explore new first-line treatments, including checkpoint...
-
Exploring Lung Cancer Care and Research in New Zealand
In this episode of 'Conversations in Lung Cancer Research' hosted by Dr Alex Davis, features a discussion with Dr. Laird Cameron and Dr. Annie Wong on the current state of lung cancer care and research in New Zealand. The panel explores the challenges and disparities faced by thoracic cancer...
-
Challenging Ageism: Optimising Lung Cancer Treatment in Older Adults
In this episode of Conversations in Lung Cancer Research, hosted by Dr Michael Krasovitsky, a medical oncologist at St. Vincent's Hospital in Sydney, the focus is on lung cancer in older adults. The distinction and application of geriatric oncology are explored through comprehensive discussions...
-
Prof. Anna Nowak: A Journey from Oncology Lab to Leadership
In this episode of Conversations in Lung Cancer Research, host A/Prof Mel Moore interviews Prof Anna Nowak, a renowned medical oncologist, clinical trialist, and tumour immunology researcher. We learn of Anna's early aspirations influenced by her family and mentors, her educational and…
more -
CNS Progression in Lung Cancer: A Practical Conversation on Best Practices
n this episode of Conversations in Lung Cancer Research, A/Prof Tim Clay discusses the multidisciplinary management of CNS metastases in the context of thoracic cancers. Joined by Dr. Keryn Davidson, a consultant neurosurgeon, and A/Prof Fiona Hegi Johnson, a radiation oncologist, the discussion...
-
A/Prof Fiona Hegi Johnson: Navigating Careers and Innovations in Lung Cancer Research
In this episode of 'Conversations in Lung Cancer Research,' A/Prof Mel Moore sits down with A/Prof Fiona Hegi Johnson, a radiation oncologist at the Peter McCallum Cancer Center and senior research fellow at the University of Melbourne. Fiona shares her journey into radiation oncology…
more -
Prof Shankar Siva: Pushing Boundaries in Radiation Oncology
In this episode of TOGA's Conversations in Lung Cancer Research, A/Prof Mel Moore speaks with Prof Shankar Siva about his groundbreaking work in radiation oncology, particularly focusing on the PRIME Lung study. They discuss the journey from concept to large clinical trials, the challenges of…
more -
The Emerging Role of the Microbiome in Lung Cancer and Immunotherapy Response
This episode of 'Conversations in Lung Cancer Research' features Dr. Anna McLean, Dr Mark Adams, and Dr Sagun Parakh, discussing research on the microbiome and its influence on lung cancer treatment outcomes. They delve into the differences between the gut and lung microbiomes, methods for…
more -
Lessons from Fellowships and building Clinical Trials Units
In this episode of Conversations in Lung Cancer Research, we welcome A/Prof Bryan Chan, a senior Medical Oncologist and this years TOGA ASM Convener. Bryan, affiliated with multiple institutions including Adam Crosby Cancer Center and Griffith University, discusses his comprehensive career…
more -
Prof Wendy Cooper: Journey of a Thoracic Pathologist
In this episode of Conversations in Lung Cancer Research, A/Prof Mel Moore speaks with Prof Wendy Cooper, a leading pathologist in cancer research. They discuss Wendy's journey into pathology, the evolution of lung cancer diagnostics, the impact of AI and liquid biopsies, and the importance of...
-
Vaccines in Thoracic Oncology: The Next Frontier in Immunotherapy
In this episode of 'Conversations in Lung Cancer Research,' Professor Tom John from the Peter MacCallum Cancer Centre in Melbourne discusses the significant progress and excitement surrounding cancer vaccines, particularly their emerging role in lung cancer treatment. He is joined by Professor…
more -
The Role of Liquid Biopsy in Modern Oncology
In this episode of Conversations in Lung Cancer Research, Dr. Malinda Itchins, Dr. Annie Wong, and A/Prof Stephen Kao discuss the concept of liquid biopsy, its advantages and limitations, and its clinical applications in lung cancer treatment. They explore how liquid biopsy can provide faster...
-
Exploring EGFR Exon 20 Insertion Mutations
In this episode of Conversations in Lung Cancer Research, A/Prof Mel Moore, along with thoracic oncologists Dr. Malinda Itchins and A/Prof Surein Arulananda, delve into the characteristics, detection, and treatment of EGFR exon 20 insertion mutant non-small cell lung cancer. The podcast discusses...
-
From Clinical Research to Leadership: A Conversation with Prof. Michael Boyer
In this episode of Conversations in Lung Cancer Research, A/Prof Mel Moore interviews Prof Michael Boyer, AM about his extensive career in medical oncology and his current role as CEO of Chris O'Brien Lifehouse. They discuss his early interest in oncology, the influential mentors in his career…
more -
Introducing Conversations in Lung Cancer Research - Trailer
In this introductory episode, Associate Professor Mel Moore, medical oncologist and education chair at TOGA, announces the evolution of TOGA podcasts to 'Conversations in Lung Cancer Research.' The podcast will continue to deliver the latest breakthroughs in lung cancer research while expanding…
more -
Navigating Resistance in ALK-Positive NSCLC Patients on TKI Therapy
We have witnessed incredible advances in therapy since ALK was discovered in 2007, starting from the pivotal PROFILE 1001 study of crizotinib in advanced ALK positive NSCLC to present day where we now have five approved targeted agents, with increasing potency, selectivity and CNS activity with...
-
Hit It With Your Best Shot- The Case for IO in Early-Stage NSCLC in a Once in a Lifetime World
Editor's Note (June 2026): This episode was recorded prior to Australia's broad PBS listing of nivolumab and ipilimumab, which has removed the previous "once in a lifetime" restriction on immunotherapy. For the latest discussion on these changes and what they mean for lung cancer care, see our...
-
Large-Cell Neuroendocrine Carcinoma of the Lung (LCNEC): Challenges in Diagnosis and Treatment
In this episode, we discuss the clinical and diagnostic markers when identifying a rare sub type of NSCLC, large-cell neuroendocrine carcinomas (LC-NEC), and provide insights into the management of these patients and future treatment developments. Associate Professor Rachel Wong, Deputy Director...
-
Management of Limited-Stage Small Cell Lung Cancer (LS-SCLC)
--------------- Support TOGA Thank you for listening to Conversations in Lung Cancer Research. If you enjoyed this episode, please rate and review us on Apple Podcasts or Spotify. --------------- Connect with TOGA Attend an Event: https://thoraciconcology.org.au/events/ Become a Member: Join the...
-
NTRK1, 2,3 And Other Rare Mutations In NSCLC
In this TOGA podcast, we provide an overview of the treatment options for rare subtypes of oncogene driven NSCLC that are now readily identified in the MBS-reimbursed small gene panel including NTRK1, 2,3 and other rare mutations in NSCLC. The importance of testing all patients is discussed as…
more -
Decoding Perioperative Immunotherapy In NSCLC
In this TOGA podcast, we provide an overview of the recent neoadjuvant, adjuvant, and perioperative IO data, the options and considerations for treatment and the current reimbursement landscape. Dr Pei Ni Ding, Medical Oncologist from Westmead and Nepean Hospitals Sydney, is joined by Dr Samantha...
-
Access to New Medicines: Which Surrogate Endpoints Matter
Do we need to evolve the bar on evidence required for drug reimbursement? The gold standard endpoint for assessing the benefit of anti-cancer drugs has been overall survival (OS) however, more recently, there has been a trend toward using surrogate clinical trial endpoints such as progression…
more -
Lung Cancer Nurses: Essential, Beneficial and a Key Link In Lung Cancer Screening
Lung Cancer Support Nurse - Lung Foundation Australia Quit Centre | Homepage Lung Cancer Screening Program: Early Detection Saves Lives (thoraciconcology.org.au) Lung Cancer Optimal Care Pathway --------------- Support TOGA Thank you for listening to Conversations in Lung Cancer Research. If you...
-
Underutilisation of Radiotherapy in Lung Cancer Treatment
Radiation therapy can be a very effective treatment for lung cancers, with 77% of patients indicating for radiation therapy in their disease trajectory. Yet, only 40% of patients with lung cancer in NSW receive radiation therapy. In this podcast, Professor Shalini Vinod, Assoc Professor Mei-Ling...
-
Revolutionising Lung Cancer Healthcare with AI: Unlocking the Future
Artificial intelligence (AI) is transforming medicine. Lung Cancer healthcare professionals are interested in the use of AI in radiology, particularly in early diagnosis leading to better patient outcomes. In this podcast we will explore how AI can aid in early detection, accurate interpretation…
more -
Antibody Drug Conjugates (ADCs) – An Emerging Treatment Platform in Lung Cancer
In this TOGA Podcast the speakers discuss Antibody Drug Conjugates (ADCs) – An Emerging Treatment Platform in Lung Cancer. The discussion explores the different molecules and mechanisms of drugs currently available, trial results and the subsequent place of ADCs in the Lung Cancer. Furthermore…
more -
Lung cancer Screening and Moving from Concept to Roll Out
This TOGA Podcast discusses Lung cancer Screening and Moving from Concept to Roll Out. The conversation explores the International Lung Cancer Screening Trial and overseas experience of recruitment, the challenges of reaching different population groups, some of whom stand to benefit most from…
more -
Early Recovery After Surgery - Guidelines and Multidisciplinary Considerations
This TOGA Podcast discusses strategies for enhancing patients’ recovery from lung cancer resection in light of new and emerging data for new peri-operative therapies that improve survival. The conversation explores the guidelines available, the changing landscape for the patient with neoadjuvant...
-
Nature and nurture: lung cancer risk and implications for future screening
This TOGA Podcast discusses the data surrounding air pollution and lung cancer. The discussion delves into Nature and nurture and lung cancer risk and implications for future screening. Associate Professor Tom John, Medical Oncologist from Peter MacCallum Cancer Centre, is joined by Professor...
-
Operability in Stage III NSCLC
In this TOGA Podcast, we discuss what defines operability in locally advanced stage III NSCLC. A/Professor Tim Clay, Medical Oncologist from St John of God Subiaco and Rockingham General is joined by Professor Lucy Morgan, Board Chair of the Lung Foundation of Australia and Respiratory Physician...
-
NSCLC and KRAS Mutations
In this TOGA Podcast, Australian medical oncologist, Associate Professor Chee Lee, St George Hospital, Kogarah, is joined by medical oncologist Dr Tristan Barnes, Royal North Shore Hospital, Sydney, and Dr Alex Davis, PhD candidate and medical oncologist at Chris O’Brien Lifehouse, Sydney. They...
-
Treatment Considerations in ALK-Positive NSCLC
In this TOGA Podcast, Australian medical oncologist Dr Jenny Lee at Chris O’Brien Lifehouse, Sydney, is joined by medical oncologist Professor Nick Pavlakis, from Royal North Shore Hospital in Sydney and Lisa Briggs, Stage IV lung cancer survivor, Author, Osteopath and Exercise Physiologist who...
-
Celebrating Female Leadership in Medical Research
In this TOGA Podcast, and on International Women’s Day 2023, we celebrate female leadership in medical research. We explore the challenges and success pathways across different career stages for women who work in medical oncology and clinical research. Associate Professor Prunella Blinman, head…
more
About this show
Welcome to Conversations in Lung Cancer Research, presented by TOGA, your go-to podcast for in-depth insights into lung cancer. Tune in for conversations with leading experts, inspiring stories, and the latest updates on clinical trials. Stay informed and empowered in the fight against lung cancer.
Hosted by
Thoracic Oncology Group Of Australasia (TOGA)